|
|
Post by kite on Aug 22, 2019 20:32:18 GMT -5
|
|
|
|
Post by kite on Aug 22, 2019 20:47:48 GMT -5
www.instagram.com/stories/thaisendocrino/Here is a video from one of the attendees talking about inhaled insulin. Unfortunately it's in Portuguese and you need to have an Instagram account to view her video. These videos normally expire in 24 hours of posting Can someone watch the video and translate for us? 
|
|
|
|
Post by kite on Aug 22, 2019 20:56:50 GMT -5
http://instagr.am/p/B1eUfe2hY1f Afrezza inhaled insulin launched at the Brazilian congress of endocrinology and metabolism update 2019 in Florianópolis. ######################### Named Afrezza®, the new insulin is sold in powder form, in cartridges with three dosage types. The use will be made by the diabetes patient by means of an inhaler - a cartridge is inserted into it so that the dust can be aspirated. The substance is carried to the lung and absorbed into the bloodstream to reduce blood glucose levels |
|
|
|
Post by kite on Aug 22, 2019 20:58:43 GMT -5
http://instagr.am/p/B1fCYiZnJT7 Ultra fast inhaled action insulin! The Biomm Brand Representative explains how to use Afrezza !! Only awaiting approval of the price to start marketing, scheduled for October 2019! Advantages - patients with type 1 and 2 diabetes to avoid multiple subcutaneous applications - well-practiced - peak action in 15 minutes, lasting 2 hours on average - can be re-signaled if keeping glucose out of target, with low risk of hypoglycemia precisely because override dose Disadvantages - Cannot be used by patients with respiratory / lung problems or smokers under 18 - high cost! |
|
|
|
Post by kite on Aug 22, 2019 21:34:49 GMT -5
|
|
|
|
Post by JEvans on Aug 23, 2019 0:29:47 GMT -5
www.instagram.com/stories/thaisendocrino/Here is a video from one of the attendees talking about inhaled insulin. Unfortunately it's in Portuguese and you need to have an Instagram account to view her video. These videos normally expire in 24 hours of posting Can someone watch the video and translate for us? She said she was going to post how to use it and that it is inhale-able human insulin, Brazilian Portuguese. My wife is from Portugal, so Brazilian Portuguese sounds a bit different. |
|
|
|
Post by sportsrancho on Aug 23, 2019 6:40:30 GMT -5
This is pretty fun they are all so excited!
|
|
|
|
Post by shake34 on Aug 24, 2019 21:27:04 GMT -5
I have lost hope in our marketing and sales of afrezza in the U.S. Mike C. says, tipping point for sales may be when pediatrics approved. That is probably 2 years away.
In the mean time, I think we should actually put some resources together with biomm and really try and sell a bunch of scripts and have some success stories there. I dont think we have to worry about fda, insurance and label there [please let me know if I'm wrong]. And maybe we can create some momentum going into pediatrics launch.
I dont think Biomm can do it on their own though.
I realize were not going to be profitable in Brazil but maybe we can gain some attention if we can have a successful launch there.
|
|
|
|
Post by barnstormer on Aug 25, 2019 6:38:11 GMT -5
Mike should put a lot of effort toward supporting BIOMM's launch. Successful manufactures always throw a high level of support to a valued distributor to make sure they are successful too. A bad launch in Brazil would give shorts more ammunition and Mannkind can't afford that. Success in Brazil would help promote Afrezza in other countries and provide Kendall with more ammunition to work on insurance and Black Box removal in US. Brazil seems excited about Afrezza. Mike can't afford to blow this opportunity even if Brazil may not add a lot of scrip revenue it will add much needed production to a manufacturing facility that will lower the overall cost per unit. A successful launch will also draw attention away from the other disctractions we are currently facing. Go Big or Stay at Home.
|
|
|
|
Post by nylefty on Aug 25, 2019 11:44:05 GMT -5
Mike should put a lot of effort toward supporting BIOMM's launch. Successful manufactures always throw a high level of support to a valued distributor to make sure they are successful too. A bad launch in Brazil would give shorts more ammunition and Mannkind can't afford that. Success in Brazil would help promote Afrezza in other countries and provide Kendall with more ammunition to work on insurance and Black Box removal in US. Brazil seems excited about Afrezza. Mike can't afford to blow this opportunity even if Brazil may not add a lot of scrip revenue it will add much needed production to a manufacturing facility that will lower the overall cost per unit. A successful launch will also draw attention away from the other disctractions we are currently facing. Go Big or Stay at Home. A reminder that Brazil doesn't allow advertising of prescription drugs. |
|
|
|
Post by awesomo on Aug 25, 2019 12:14:57 GMT -5
Mike should put a lot of effort toward supporting BIOMM's launch. Successful manufactures always throw a high level of support to a valued distributor to make sure they are successful too. A bad launch in Brazil would give shorts more ammunition and Mannkind can't afford that. Success in Brazil would help promote Afrezza in other countries and provide Kendall with more ammunition to work on insurance and Black Box removal in US. Brazil seems excited about Afrezza. Mike can't afford to blow this opportunity even if Brazil may not add a lot of scrip revenue it will add much needed production to a manufacturing facility that will lower the overall cost per unit. A successful launch will also draw attention away from the other disctractions we are currently facing. Go Big or Stay at Home. A reminder that Brazil doesn't allow advertising of prescription drugs. The U.S. and New Zealand are the only two countries that allow advertising of prescription drugs. Gotta make those ad dollars! |
|
|
|
Post by barnstormer on Aug 25, 2019 12:36:42 GMT -5
Interesting response NY. You always like to attack my posts. There are many ways companies support their distributors without DTC. The support I was talking about is feet on the ground helping out with training, providing materials for endos and educators. Attending conferences and other promotions like they do with JDRF. Ther are a multitude of ways Mike can help without advertising. We hardly do it here.
|
|
|
|
Post by nylefty on Aug 25, 2019 13:12:48 GMT -5
Interesting response NY. You always like to attack my posts. There are many ways companies support their distributors without DTC. The support I was talking about is feet on the ground helping out with training, providing materials for endos and educators. Attending conferences and other promotions like they do with JDRF. Ther are a multitude of ways Mike can help without advertising. We hardly do it here. Attack? Paranoid much? I don't disagree with you on this issue - was just pointing out that prescription drug advertising isn't allowed in Brazil. |
|
|
|
Post by mytakeonit on Aug 25, 2019 16:08:49 GMT -5
Brazil is so crowded that if you say "Afrezza" loudly ... everyone will hear it.
But, that's mytakeonit
|
|
|
|
Post by Clement on Aug 25, 2019 16:30:25 GMT -5
Brazil is so crowded that if you say "Afrezza" loudly ... everyone will hear it. But, that's mytakeonit "AFREZZA!" "Bless you." |
|
